Urzua CA - Search Results

1

Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome.

Urzua CA, Vasquez DH, Huidobro A, Hernandez H, Alfaro J. Urzua CA, et al. Curr Eye Res. 2012 Aug;37(8):684-8. doi: 10.3109/02713683.2012.674609. Epub 2012 Jun 6. Curr Eye Res. 2012. PMID: 22670856 Clinical Trial.

2

Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.

Urzua CA, Velasquez V, Sabat P, Berger O, Ramirez S, Goecke A, Vásquez DH, Gatica H, Guerrero J. Urzua CA, et al. Acta Ophthalmol. 2015 Sep;93(6):e475-80. doi: 10.1111/aos.12648. Epub 2015 Jan 7. Acta Ophthalmol. 2015. PMID: 25565265 Free article.

3

Clinical Features and Prognostic Factors in Presumed Ocular Tuberculosis.

Urzua CA, Lantigua Y, Abuauad S, Liberman P, Berger O, Sabat P, Velasquez V, Castiglione E, Calonge M. Urzua CA, et al. Curr Eye Res. 2017 Jul;42(7):1029-1034. doi: 10.1080/02713683.2016.1266663. Epub 2017 Feb 3. Curr Eye Res. 2017. PMID: 28157425

4

Successful treatment of cytomegalovirus retinitis with oral/intravitreal antivirals in HIV-negative patients with lymphoma.

Tasiopoulou A, Urzua CA, Lightman S. Tasiopoulou A, et al. Among authors: urzua ca. Eye (Lond). 2023 Jun;37(9):1895-1903. doi: 10.1038/s41433-022-02267-0. Epub 2022 Oct 3. Eye (Lond). 2023. PMID: 36192634 Free PMC article.

5

"White dot syndromes", an inappropriate and outdated misnomer.

Neri P, Herbort CP Jr, Hedayatfar A, Tugal-Tutkun I, Cimino L, Urzua CA, Papasavvas I, Takeuchi M, Lages V. Neri P, et al. Among authors: urzua ca. Int Ophthalmol. 2022 Jan;42(1):1-6. doi: 10.1007/s10792-021-02121-4. Int Ophthalmol. 2022. PMID: 34783928 No abstract available.

6

Evaluation of the Glucocorticoid Receptor as a Biomarker of Treatment Response in Vogt-Koyanagi-Harada Disease.

Urzua CA, Guerrero J, Gatica H, Velasquez V, Goecke A. Urzua CA, et al. Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):974-980. doi: 10.1167/iovs.16-20783. Invest Ophthalmol Vis Sci. 2017. PMID: 28535268

7

Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review.

Herbort CP Jr, Tugal-Tutkun I, Abu-El-Asrar A, Gupta A, Takeuchi M, Fardeau C, Hedayatfar A, Urzua C, Papasavvas I. Herbort CP Jr, et al. Eye (Lond). 2022 Jan;36(1):29-43. doi: 10.1038/s41433-021-01573-3. Epub 2021 Jun 18. Eye (Lond). 2022. PMID: 34145419 Free PMC article. Review.

8

Causes of Uveitis in a Tertiary Center in Chile: A Cross-sectional Retrospective Review.

Liberman P, Gauro F, Berger O, Urzua CA. Liberman P, et al. Among authors: urzua ca. Ocul Immunol Inflamm. 2015 Aug;23(4):339-345. doi: 10.3109/09273948.2014.981548. Epub 2014 Dec 1. Ocul Immunol Inflamm. 2015. PMID: 25437569

9

Evaluation of the Accuracy of T-SPOT.TB for the Diagnosis of Ocular Tuberculosis in a BCG-vaccinated, Non-endemic Population.

Urzua CA, Liberman P, Abuauad S, Sabat P, Castiglione E, Beltran-Videla MA, Aguilera R. Urzua CA, et al. Ocul Immunol Inflamm. 2017 Aug;25(4):455-459. doi: 10.3109/09273948.2015.1135965. Epub 2016 Mar 4. Ocul Immunol Inflamm. 2017. PMID: 26942470

10

Diabetes Mellitus-Associated Uveitis: Clinical Features in a Chilean Series.

Sabat PE, Anguita R, Saez V, Morales S, Urzúa CA, Villarroel FA, Velásquez V. Sabat PE, et al. Among authors: urzua ca. Ocul Immunol Inflamm. 2020 May 18;28(4):571-574. doi: 10.1080/09273948.2019.1581226. Epub 2019 Feb 27. Ocul Immunol Inflamm. 2020. PMID: 30811256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page